(Q53048153)

English

CD49d shows superior performance characteristics for flow cytometric prognostic testing in chronic lymphocytic leukemia/small lymphocytic lymphoma.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/27221715

CD49d shows superior performance characteristics for flow cytometric prognostic testing in chronic lymphocytic leukemia/small lymphocytic lymphoma. (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/27221715

0 references

1 reference

based on heuristic

inferred from title

author name string

Casey E Gooden

1

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/27221715

Patricia Jones

2

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/27221715

Ruth Bates

3

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/27221715

Wendy M Shallenberger

4

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/27221715

Urvashi Surti

5

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/27221715

Steven H Swerdlow

6

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/27221715

Christine G Roth

7

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/27221715

publication date

27 June 2016

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/27221715

Cytometry Part B: Clinical Cytometry

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/27221715

94

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/27221715

1

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/27221715

129-135

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/27221715

A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

How I treat CLL up front

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Genomic aberrations and survival in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Is ZAP70 still a key prognostic factor in early stage chronic lymphocytic leukaemia? Results of the analysis from a prospective multicentre observational study.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Prognostic markers in chronic lymphocytic leukemia: a comprehensive review

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Pitfalls and limitations of ZAP-70 detection in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Evaluation of ZAP-70 expression by flow cytometry in chronic lymphocytic leukemia: A multicentric international harmonization process

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

CD49d is the strongest flow cytometry-based predictor of overall survival in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

CD49d is an independent prognostic marker that is associated with CXCR4 expression in CLL.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Do biologic parameters affect the time to first treatment of clinical monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Rai stage 0? Results of a prospective analysis.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

CD49d expression is an independent risk factor of progressive disease in early stage chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

High CD49d protein and mRNA expression predicts poor outcome in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Idelalisib and rituximab in relapsed chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Treatment with Ibrutinib Inhibits BTK- and VLA-4-Dependent Adhesion of Chronic Lymphocytic Leukemia Cells In Vivo

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Improved ZAP‐70 assay using two clones, multiple methods of analysis and clinical correlation

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Correlation of flow cytometrically determined expression of ZAP-70 using the SBZAP antibody with IgVH mutation status and cytogenetics in 1,229 patients with chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Prognostic value of ZAP-70 expression in chronic lymphocytic leukemia as assessed by quantitative polymerase chain reaction and flow cytometry.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Combined normal donor and CLL: Single tube ZAP-70 analysis

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Methodological comparison of two anti‐ZAP‐70 antibodies

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Trisomy 12 chronic lymphocytic leukemia cells exhibit upregulation of integrin signaling that is modulated by NOTCH1 mutations

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Circulating B-cell chronic lymphocytic leukemia cells display impaired migration to lymph nodes and bone marrow.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Microenvironmental interactions in chronic lymphocytic leukemia: the master role of CD49d.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Differential bone marrow homing capacity of VLA-4 and CD38 high expressing chronic lymphocytic leukemia cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Trisomy 12 CLLs progress through NOTCH1 mutations

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

NOTCH1 mutations in CLL associated with trisomy 12.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

CD49d (ITGA4) expression is a predictor of time to first treatment in patients with chronic lymphocytic leukaemia and mutatedIGHVstatus

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanism

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative analysis of flow cytometric techniques in assessment of ZAP-70 expression in relation to IgVH mutational status in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

7 January 2021

based on heuristic

inferred from DOI database lookup

ZAP-70 by flow cytometry: a comparison of different antibodies, anticoagulants, and methods of analysis

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

7 January 2021

based on heuristic

inferred from DOI database lookup

Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

7 January 2021

based on heuristic

inferred from DOI database lookup

Zeta-chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

7 January 2021

based on heuristic

inferred from DOI database lookup

CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

7 January 2021

based on heuristic

inferred from DOI database lookup

CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective validation of a risk score based on biological markers for predicting progression free survival in Binet stage A chronic lymphocytic leukemia patients: Results of the multicenter O-CLL1-GISL study

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimization of flow cytometric measurement of ZAP-70 in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

7 January 2021

based on heuristic

inferred from DOI database lookup

ZAP-70 in CLL: towards standardization of a biomarker for patient management: history of clinical cytometry special issue

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

7 January 2021

based on heuristic

inferred from DOI database lookup

A robust ratio metric method for analysis of Zap-70 expression in chronic lymphocytic leukemia (CLL)

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

7 January 2021

based on heuristic

inferred from DOI database lookup

CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CYTO.B.21384

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/27221715

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/27221715

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53048153&oldid=1492867934"